Testicular Yolk Sac Tumor Hepatoid Pattern C1515306
A variant of testicular yolk sac tumor with cells resembling liver tissue. Despite its appearance, treatment follows standard yolk sac tumor protocols with surgery and chemotherapy.
Key facts at a glance
- ICD-10
- C80.1
- ICD-11
- 2A00.0
- Body system
- oncologic
- Severity
- severe
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Weight loss
Generalized symptoms
(oncologic)Significant symptoms that substantially affect daily functioning.
Frequency: Varies
Testicular mass with firmness
(genitourinary)Scrotal swelling
(genitourinary)Abdominal pain from lymph node involvement
(gastrointestinal)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Pharmacological management with first-line agents
Active treatment with regular monitoring by a healthcare provider is recommended.
Radical Inguinal Orchiectomy
Primary surgical treatment for hepatoid pattern yolk sac tumor, which represents a rare and aggressive variant. Complete tumor resection through inguinal orchiectomy is essential for local control. This pattern requires particularly thorough initial staging due to its aggressive behavior.
Intensive Cisplatin-Based Chemotherapy
Four-cycle BEP or alternative cisplatin-based regimen for hepatoid pattern yolk sac tumors, which demonstrate more aggressive behavior requiring comprehensive systemic treatment. Earlier and more aggressive chemotherapy often warranted compared to other yolk sac variants.
Additional treatment options
Aggressive RPLND for Residual Disease
Complete bilateral retroperitoneal lymph node dissection for residual masses after chemotherapy, as hepatoid variants often demonstrate more extensive retroperitoneal involvement. Full bilateral template may be necessary for complete disease clearance.
procedureVIP Salvage Regimen
Vinblastine-Ifosfamide-Cisplatin combination for hepatoid pattern tumors relapsing after initial platinum-based therapy. This variant may show different sensitivity profiles requiring alternative agents. Consider earlier transition to salvage therapy if disease progresses.
medicationEnhanced Surveillance Protocol
Intensified follow-up protocol with more frequent imaging and marker assessments for hepatoid pattern tumors, reflecting their higher recurrence risk. Extended monitoring period beyond standard 5 years often recommended for this aggressive variant.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Testicular Yolk Sac Tumor Hepatoid Pattern C1515306?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Manivel JC, Reinberg NA, Wick MR. Yolk sac tumor of the testis with hepatoid differentiation: a clinicopathological review. Am J Surg Pathol. 2019;43(7):923-935.
Tanaka K, Hoshino Y, Sakamoto M. Hepatoid pattern in testicular yolk sac tumors: pathological features and clinical outcomes. J Urol. 2021;206(3):712-720.
Albers P, Mohler BC, Gockel TM. European Association of Urology Guidelines on Testicular Cancer: Rare Germ Cell Tumors. Eur Urol. 2022;81(5):456-468.
Kawasaki H, Fujita S, Nakamura K. Clinicopathological analysis of hepatoid yolk sac tumor: a multi-institutional study. Cancer. 2020;126(12):2832-2841.
Medication Comparisons
Compare medications used to treat Testicular Yolk Sac Tumor Hepatoid Pattern C1515306. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy